Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0757
G

Failure to Discontinue Unnecessary Medications Resulting in Resident Decline

Cheyenne, Wyoming Survey Completed on 10-24-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that a resident’s drug regimen was free from unnecessary medications, resulting in a significant decline in the resident’s functional status. The resident, who was severely cognitively impaired and initially independent with mobility, was administered multiple medications including valproic acid, lacosamide, olanzapine, melatonin, and paroxetine. Despite a neurologist’s order to discontinue valproic acid and switch to lacosamide, the facility continued to administer valproic acid for an extended period. The medication administration records showed overlapping use of anticonvulsants and other psychotropic medications, with changes and discontinuations not aligning with hospital discharge instructions or family requests. The resident’s representative reported that the resident’s decline began shortly after participating in a facility event, and that the facility did not follow the neurologist’s orders to discontinue valproic acid. Hospital records indicated the resident was seen for altered mental status and somnolence, with explicit instructions to stop valproic acid and increase lacosamide if needed. However, the facility’s records showed continued administration of valproic acid even after these instructions, and the medication was not discontinued until several weeks later. Nursing notes and interviews with staff confirmed the resident’s decline in mobility and self-care, with staff unable to identify the cause at the time. Further review revealed that the resident was also receiving other medications with sedative effects, and a drug interaction check indicated a significant risk of increased sedation and drowsiness from the combination of valproic acid, olanzapine, and melatonin. Interviews with the DON and NHA confirmed a lack of awareness of the medication management issues during the period in question. The failure to appropriately manage and monitor the resident’s medication regimen led to a decline from independence to total dependence in mobility and self-care.

An unhandled error has occurred. Reload 🗙